Physician profile
Ashley M Eiferle
NPI 1457776999
$2,158.97
in general payments reported to CMS, 2019-2025
19 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $563 · 2023: $457 · 2024: $449 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $324.42 | 2024-2025 | Affera Mapping System, Na, Flexcath Contour |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.16 | 2022 | |
| Philips North America LLC | $198.60 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Abiomed | $157.25 | 2023-2024 | Impella |
| Atricure, INC. | $155.75 | 2022 | |
| Boston Scientific Corporation | $150.33 | 2023 | Watchman Access System |
| Biohaven Pharmaceuticals, INC. | $125.72 | 2021 | |
| Abbvie INC. | $125.49 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $117.92 | 2022 | |
| Redhill Biopharma INC. | $116.92 | 2021 | |
| Scynexis, INC. | $88.57 | 2022 | |
| Pfizer INC. | $84.53 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $79.62 | 2021 | |
| Abbott Laboratories | $51.40 | 2024-2025 | Cardiomems |
| Amgen INC. | $50.83 | 2024 | Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $45.77 | 2023-2024 | Definity |
| E.R. Squibb & Sons, L.L.C. | $40.09 | 2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $33.23 | 2023 | |
| Genentech USA, INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Eiferle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.